Inventor · disambiguated record
Johan Frostegård
Also filed as: FROSTEGAARD JOHAN · FROSTEGAERD JOHAN · FROSTEGARD JOHAN · FROSTEGÅRD JOHAN
13 granted patents·16 pending applications·32 citations·filing 1999–2023
88Inventor score
Files withATHERA BIOTECHNOLOGIES AB13ANNEXIN PHARMACEUTICALS AB8FROSTEGAARD JOHAN2CEDERHOLM ANNA1DE FAIRE ULF1
Top patents by PatentIndex Score
29 records- 0184US8012483B2Phosphorylcholine conjugates and corresponding antibodiesATHERA BIOTECHNOLOGIES AB·Filed 2005·Granted Sep 6, 2011·12 cites·13 claims
- 0276US10669332B2Phosphorylcholine in combination therapy with infliximabATHERA BIOTECHNOLOGIES AB·Filed 2016·Granted Jun 2, 2020·1 cites·2 claims
- 0375US10752680B2Antibodies against phosphorylcholine in combination therapy with biologic agentsATHERA BIOTECHNOLOGIES AB·Filed 2016·Granted Aug 25, 2020·1 cites·2 claims
- 0470US9295716B2Methods for treating restenosis using annexin A5PETTERSSON KNUT·Filed 2009·Granted Mar 29, 2016·1 cites·19 claims
- 0569US2021389310A1Oxidized cardiolipin as a pro-inflammatory factorANNEXIN PHARMACEUTICALS AB·Filed 2021·Application pending·0 cites
- 0668US10222382B2Phosphorylcholine conjugates and corresponding antibodiesATHERA BIOTECHNOLOGIES AB·Filed 2014·Granted Mar 5, 2019·1 cites·20 claims
- 0768US2021032359A1Antibodies against phosphorylcholine in combination therapy with biologic agentsATHERA BIOTECHNOLOGIES AB·Filed 2020·Application pending·0 cites
- 0867US2020262906A1Antibodies against phosphorylcholine in combination therapy with biologic agentsATHERA BIOTECHNOLOGIES AB·Filed 2020·Application pending·0 cites
- 0966US10060908B2Oxidized cardiolipin as a pro-inflammatory factorMEDIRISTA BIOTECHNOLOGIES AB·Filed 2013·Granted Aug 28, 2018·1 cites·18 claims
- 1066US2011250208A1Oxidized Cardiolipin as a Novel Pro-Inflammatory FactorFROSTEGAARD JOHAN·Filed 2009·Application pending·0 cites
- 1161US2025339544A1Composition, methods and usesINFLANOVA AB·Filed 2023·Application pending·0 cites
- 1260US9649355B2Compounds and methods for the treatment of vascular diseaseANNEXIN PHARMACEUTICALS AB·Filed 2014·Granted May 16, 2017·0 cites·8 claims
- 1358US8809497B2Compounds and methods for the treatment of vascular diseaseFROSTEGARD JOHAN·Filed 2008·Granted Aug 19, 2014·0 cites·2 claims
- 1458US2019086395A1Oxidized cardiolipin as a pro-inflammatory factorANNEXIN PHARMACEUTICALS AB·Filed 2018·Application pending·0 cites
- 1555US7662577B2Method of diagnosing cardiovascular diseaseATHERA BIOTECHNOLOGIES AB·Filed 2004·Granted Feb 16, 2010·1 cites·25 claims
- 1655US2011206679A1New Therapeutic and Diagnostic Methods for Alzheimer's DiseaseATHERA BIOTECHNOLOGIES AB·Filed 2009·Application pending·0 cites
- 1754US9682122B2Compounds and methods for the treatment of vascular diseaseANNEXIN PHARMACEUTICALS AB·Filed 2016·Granted Jun 20, 2017·0 cites·3 claims
- 1853US2013309696A1Therapeutic and diagnostic methods for alzheimer's diseaseATHERA BIOTECHNOLOGIES AB·Filed 2013·Application pending·0 cites
- 1953US2013004491A1Antibodies Against Phosphorylcholine In Combination Therapy with Biologic AgentsFROSTEGAARD JOHAN·Filed 2011·Application pending·0 cites
- 2052US6780605B1Method of diagnosing cardiovascular disease and early atherosclerosisATHERA BIOTECHNOLOGIES AB·Filed 1999·Granted Aug 24, 2004·14 cites·12 claims
- 2152US2015346220A1Therapeutic and diagnostic methods for alzheimer's diseaseATHERA BIOTECHNOLOGIES AB·Filed 2015·Application pending·0 cites
- 2251US2018140668A1Methods for treating restenosis using annexin a5ANNEXIN PHARMACEUTICALS AB·Filed 2018·Application pending·0 cites
- 2350US9901614B2Methods for treating restenosis using annexin A5ANNEXIN PHARMACEUTICALS AB·Filed 2016·Granted Feb 27, 2018·0 cites·19 claims
- 2448US2012039895A1Phosphorycholine conjugates and corresponding antibodiesDE FAIRE ULF·Filed 2011·Application pending·0 cites
- 2547US2010278836A1Diagnostic and therapeutic methods and compositions for cardiovascular diseaseATHERA BIOTECHNOLOGIES AB·Filed 2008·Application pending·0 cites
- 2647US2016131661A1Phosphorylcholine conjugates and corresponding antibodiesATHERA BIOTECHNOLOGIES AB·Filed 2015·Application pending·0 cites
- 2739US11801283B2Therapeutic compositionsANNEXIN PHARMACEUTICALS AB·Filed 2018·Granted Oct 31, 2023·0 cites·22 claims
- 2839US2008044404A1Annexin V for Preventing Atherothrombosis and Plaque RuptureCEDERHOLM ANNA·Filed 2005·Application pending·0 cites
- 2934US2017239329A1Therapeutic composition comprising annexin vANNEXIN PHARMACEUTICALS AB·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Johan Frostegård files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →